SIGN UP
LOG IN
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga·08/06/2025 17:06:59
Listen to the news
Gainers
- Myriad Genetics (NASDAQ:MYGN) shares increased by 41.9% to $5.49 during Wednesday's regular session. The company's market cap stands at $356.7 million. The company's, Q2 earnings came out yesterday.
- Claritev (NYSE:CTEV) stock rose 30.28% to $51.49. The company's market cap stands at $649.5 million. As per the press release, Q2 earnings came out today.
- Ainos (NASDAQ:AIMD) stock moved upwards by 29.13% to $2.97. The company's market cap stands at $9.7 million.
- CryoPort (NASDAQ:CYRX) shares rose 28.85% to $8.69. The company's market cap stands at $336.3 million. As per the news, the Q2 earnings report came out yesterday.
- BiomX (AMEX:PHGE) stock rose 28.66% to $0.56. The market value of their outstanding shares is at $11.3 million.
- Hinge Health (NYSE:HNGE) stock rose 24.53% to $60.05. The market value of their outstanding shares is at $3.7 billion. The company's, Q2 earnings came out yesterday.
Losers
- Fractyl Health (NASDAQ:GUTS) shares declined by 47.0% to $0.99 during Wednesday's regular session. The company's market cap stands at $91.5 million.
- LifeMD (NASDAQ:LFMD) shares fell 45.36% to $6.47. The market value of their outstanding shares is at $538.0 million. As per the press release, Q2 earnings came out yesterday.
- Evolus (NASDAQ:EOLS) shares fell 33.11% to $5.96. The company's market cap stands at $574.4 million. As per the press release, Q2 earnings came out yesterday.
- Lantheus Holdings (NASDAQ:LNTH) shares decreased by 30.47% to $50.5. The market value of their outstanding shares is at $5.0 billion. The company's, Q2 earnings came out today.
- BioVie (NASDAQ:BIVI) stock fell 24.2% to $3.76. The company's market cap stands at $9.2 million.
- Personalis (NASDAQ:PSNL) shares declined by 23.05% to $4.33. The company's market cap stands at $477.6 million. As per the press release, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.